. "500 patients that can be used by researchers to study a range of diseases including diabetes and dementia,??? explained Martin Graf, head of the stem cell platform and coordinator of the project. ???The cell lines will help implement patient models that will facilitate the drug development process thanks to the possibility of reproducing the disease mechanism in vitro.??? The ten companies include" . . .